论文部分内容阅读
RIEKEN M,XYLINAS E,KLUTH L,et al.Eur Urol,2013Aug 27[Epub ahead of print]背景目前调查膀胱TaG1期尿路上皮癌(UCB)的自然病程的研究还少有报道。目的评估膀胱TaG1期尿路上皮癌患者的长期预后和术后即刻灌注化疗(IPIC)的影响。方法对1996~2007年间在8个中心的1 447例TaG1UCB患者进行回顾性分析。中位随访时间为67.2个月。按欧洲泌尿学会(EAU)指南将患者分为三个风险类别;高危患者(n=11)
RIEKEN M, XYLINAS E, KLUTH L, et al. Eur Urol, 2013 Aug 27 [Epub ahead of print] Background There is little research into the natural history of bladder TaG1 stage urothelial carcinoma (UCB). Objective To evaluate the long-term prognosis of bladder TaG1 stage urothelial carcinoma and the effect of immediate postoperative infusion chemotherapy (IPIC). Methods A retrospective analysis of 1 447 TaG1UCB patients in 8 centers between 1996 and 2007 was conducted. The median follow-up time was 67.2 months. Patients were divided into three risk groups according to the European Urological Association (EAU) guidelines; high-risk patients (n = 11)